<DOC>
	<DOCNO>NCT00979017</DOCNO>
	<brief_summary>The primary objective study determine efficacy Avastin combination temozolomide irinotecan term response rate . The secondary objective describe overall progression-free survival unresectable patient treat upfront Avastin , temozolomide irinotecan ass safety Avastin , temozolomide irinotecan unresectable glioblastoma patient . This phase II study combination Avastin , temozolomide irinotecan unresectable multifocal World Health Organization ( WHO ) grade IV malignant glioma patient . Patients receive four cycle Avastin , temozolomide irinotecan . Approximately 41 subject take part study Duke .</brief_summary>
	<brief_title>Avastin/Temozolomide/Irinotecan Unresectable/Multifocal Glioblastoma Multiforme</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Gliosarcoma</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Patients must histologically confirm diagnosis WHO grade IV primary malignant glioma ( glioblastoma multiforme gliosarcoma ) . Patients unresectable multifocal disease . Age &gt; = 18 year life expectancy &gt; 12 week . Evidence measurable primary Central Nervous System ( CNS ) neoplasm contrast enhance MRI . An interval least one week prior biopsy four week surgical resection enrollment protocol . Karnofsky &gt; = 60 % . Hemoglobin &gt; = 9g/dl , absolute neutrophil count ( ANC ) &gt; = 1,500 cells/microliter , platelet &gt; = 125,000 cells/microliter . Serum creatinine ≤ 1.5 mg/dl , serum serum glutamic oxaloacetic transaminase ( SGOT ) direct bilirubin ≤ 1.5 time upper limit normal ( total bilirubin great equal 1.5 x upper limit normal , direct bilirubin must ≤ 1.5 x upper limit normal ) . Signed informed consent approve Institutional Review Board prior patient entry . If sexually active , patient take contraceptive measure duration treatment . Pregnancy breast feeding Comedication may interfere study result ; e.g . immunosuppressive agent corticosteroid . Active infection require IV antibiotic . Treatment radiotherapy chemotherapy brain tumor , irrespective grade tumor . Evidence &gt; grade 1 CNS hemorrhage baseline MRI CT scan . Avastinspecific Inadequately control hypertension ( define systolic blood pressure &gt; 150 and/or diastolic blood pressure &gt; 100 mmHg antihypertensive medication ) Any prior history hypertensive crisis hypertensive encephalopathy New York Heart Association ( NYHA ) Grade II great congestive heart failure History myocardial infarction unstable angina within 6 month prior study enrollment History stroke transient ischemic attack within 6 month prior study enrollment Significant vascular disease ( e.g. , aortic aneurysm , aortic dissection ) Symptomatic peripheral vascular disease Evidence bleed diathesis coagulopathy Major surgical procedure , open biopsy , significant traumatic injury within 28 day prior study enrollment anticipation need major surgical procedure course study Core biopsy minor surgical procedure , exclude placement vascular access device , within 7 day prior study enrollment History abdominal fistula , gastrointestinal perforation , intraabdominal abscess within 6 month prior study enrollment Serious , nonhealing wound , ulcer , bone fracture Proteinuria screening demonstrate either urine protein : creatinine ( UPC ) ratio &gt; = 1.0 screening OR urine dipstick proteinuria ≥ 2+ ( patient discover ≥2+ proteinuria dipstick urinalysis baseline undergo 24hour urine collection must demonstrate ≤ 1g protein 24 hour eligible ) . Known hypersensitivity component Avastin Pregnant ( positive pregnancy test ) lactating . Use effective mean contraception ( men woman ) subject childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>malignant glioma</keyword>
	<keyword>glioblastoma multiforme</keyword>
	<keyword>gliosarcoma</keyword>
	<keyword>Avastin</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>Temodar</keyword>
	<keyword>temozolomide</keyword>
	<keyword>Irinotecan</keyword>
	<keyword>CPT-11</keyword>
	<keyword>Pro00019065</keyword>
	<keyword>Vredenburgh</keyword>
	<keyword>Duke</keyword>
</DOC>